CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Retained Earnings (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income	Total New Residential Stockholders’ Equity	Total New Residential Stockholders’ Equity Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling Interests in Equity of Consolidated Subsidiaries	Noncontrolling Interests in Equity of Consolidated Subsidiaries Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Common Stock Common Stock	Common Stock Additional Paid-in Capital	Common Stock Total New Residential Stockholders’ Equity	Preferred Stock	Preferred Stock Preferred Stock	Preferred Stock Total New Residential Stockholders’ Equity
Balance, beginning (in shares) at Dec. 31, 2018			0	369,104,429
Balance, beginning at Dec. 31, 2018	$ 6,088,295		$ 0	$ 3,692	$ 4,746,242	$ 830,713		$ 417,023	$ 5,997,670		$ 90,625
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock						(830,995)							$ (830,995)			$ (830,995)
Dividends declared on preferred stock	(13,281)					(13,281)			(13,281)
Capital distributions	(54,712)										(54,712)
Issuance stock (in shares)														46,000,000				17,510,000
Issuance of stock													751,393	$ 460	$ 750,933	751,393	$ 423,444	$ 423,444	$ 423,444
Option exercise (in shares)				348,613
Option exercise				$ 3	(3)
Director share grants (in shares)				67,738
Director share grants	1,055			$ 1	1,054				1,055
Comprehensive income (loss)
Net income (loss)	605,933					563,296			563,296		42,637
Unrealized gain (loss) on available-for-sale securities, net	445,943							445,943	445,943
Reclassification of net realized (gain) loss on available-for-sale securities, net into net income	(180,815)							(180,815)	(180,815)
Comprehensive income (loss)	871,061								828,424		42,637
Balance, ending (in shares) at Dec. 31, 2019			17,510,000	415,520,780
Balance, ending at Dec. 31, 2019	$ 7,236,260	$ 30,453	$ 423,444	$ 4,156	5,498,226	549,733	$ 13,658	682,151	7,157,710	$ 13,658	78,550	$ 16,795
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]
2020 Warrants	$ 53,462				53,462				53,462
Dividends declared on common stock						(207,667)							(207,667)			(207,667)
Dividends declared on preferred stock	(54,295)					(54,295)			(54,295)
Capital contributions	2,449										2,449
Capital distributions	$ (41,800)										(41,800)
Issuance stock (in shares)														97,394				16,100,000
Issuance of stock													1,663	$ 1	1,662	1,663	389,548	$ 389,548	389,548
Option exercise (in shares)	0
Repurchase of common stock (in shares)														(1,000,000)
Repurchase of common stock													(7,462)	$ (10)	(7,452)	(7,462)
Director share grants (in shares)				126,344
Director share grants	$ 1,211			$ 1	1,210				1,211
Comprehensive income (loss)
Net income (loss)	(1,357,684)					(1,410,358)			(1,410,358)		52,674
Unrealized gain (loss) on available-for-sale securities, net	123,855							123,855	123,855
Reclassification of net realized (gain) loss on available-for-sale securities, net into net income	(740,309)							(740,309)	(740,309)
Comprehensive income (loss)	(1,974,138)								(2,026,812)		52,674
Balance, ending (in shares) at Dec. 31, 2020			33,610,000	414,744,518
Balance, ending at Dec. 31, 2020	5,429,684		$ 812,992	$ 4,148	5,547,108	(1,108,929)		65,697	5,321,016		108,668
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(409,595)					(409,595)			(409,595)
Dividends declared on preferred stock	(66,744)					(66,744)			(66,744)
Capital distributions	$ (55,600)										(55,600)
Issuance stock (in shares)														51,903,346				18,600,000
Issuance of stock													$ 513,421	$ 519	$ 512,902	$ 513,421	$ 449,489	$ 449,489	$ 449,489
Option exercise (in shares)	0
Purchase of non-controlling interest	$ (22,523)				(1,447)				(1,447)		(21,076)
Director share grants (in shares)				110,402
Director share grants	1,110			$ 2	1,108				1,110
Comprehensive income (loss)
Net income (loss)	805,582					772,226			772,226		33,356
Unrealized gain (loss) on available-for-sale securities, net	29,944							29,944	29,944
Reclassification of net realized (gain) loss on available-for-sale securities, net into net income	(5,388)							(5,388)	(5,388)
Comprehensive income (loss)	830,138								796,782		33,356
Balance, ending (in shares) at Dec. 31, 2021			52,210,000	466,758,266
Balance, ending at Dec. 31, 2021	$ 6,669,380		$ 1,262,481	$ 4,669	$ 6,059,671	$ (813,042)		$ 90,253	$ 6,604,032		$ 65,348